GR3022730T3 - 27-hydroxyrapamycin and derivatives thereof. - Google Patents
27-hydroxyrapamycin and derivatives thereof.Info
- Publication number
- GR3022730T3 GR3022730T3 GR970400422T GR970400422T GR3022730T3 GR 3022730 T3 GR3022730 T3 GR 3022730T3 GR 970400422 T GR970400422 T GR 970400422T GR 970400422 T GR970400422 T GR 970400422T GR 3022730 T3 GR3022730 T3 GR 3022730T3
- Authority
- GR
- Greece
- Prior art keywords
- hydroxyrapamycin
- derivatives
- formula
- compound
- deoxo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93012492A | 1992-08-13 | 1992-08-13 | |
| US08/009,605 US5256790A (en) | 1992-08-13 | 1993-01-27 | 27-hydroxyrapamycin and derivatives thereof |
| PCT/US1993/007581 WO1994004540A1 (en) | 1992-08-13 | 1993-08-12 | 27-hydroxyrapamycin and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3022730T3 true GR3022730T3 (en) | 1997-06-30 |
Family
ID=26679675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970400422T GR3022730T3 (en) | 1992-08-13 | 1997-03-03 | 27-hydroxyrapamycin and derivatives thereof. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0655065B1 (enExample) |
| JP (1) | JPH08501084A (enExample) |
| AT (1) | ATE146179T1 (enExample) |
| AU (1) | AU5007193A (enExample) |
| CA (1) | CA2142288A1 (enExample) |
| DE (1) | DE69306585T2 (enExample) |
| DK (1) | DK0655065T3 (enExample) |
| ES (1) | ES2096941T3 (enExample) |
| GR (1) | GR3022730T3 (enExample) |
| HU (1) | HU221499B (enExample) |
| MX (1) | MX9304868A (enExample) |
| WO (1) | WO1994004540A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995014023A1 (en) * | 1993-11-19 | 1995-05-26 | Abbott Laboratories | Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| US5527907A (en) * | 1993-11-19 | 1996-06-18 | Abbott Laboratories | Macrolide immunomodulators |
| US6187757B1 (en) | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
| CZ292233B6 (cs) * | 1995-06-09 | 2003-08-13 | Novartis Ag | Deriváty rapamycinu a jejich použití jako léčiv |
| AU783158B2 (en) | 1999-08-24 | 2005-09-29 | Ariad Pharmaceuticals, Inc. | 28-epirapalogs |
| US7067526B1 (en) | 1999-08-24 | 2006-06-27 | Ariad Gene Therapeutics, Inc. | 28-epirapalogs |
| BR0307544A (pt) | 2002-02-01 | 2004-12-07 | Ariad Gene Therapeutics Inc | Compostos contendo fósforos, componentes e composição bem como, sua utilização através de métodos de tratamentos |
| US20040225077A1 (en) | 2002-12-30 | 2004-11-11 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
| CA2669415A1 (en) | 2006-11-14 | 2008-05-22 | Ariad Pharmaceuticals, Inc. | Solid dosage form comprising ap23573 |
| EP2245165A4 (en) | 2008-01-11 | 2011-06-01 | Massachusetts Eye & Ear Infirm | TRANSGENIC CONDITIONAL STOP DIMERICABLE CASPASE ANIMALS |
| CN105283553B (zh) | 2013-06-11 | 2021-06-25 | 克隆技术实验室有限公司 | 蛋白质富集的微泡及其制备和使用方法 |
| CA3098698A1 (en) | 2018-05-01 | 2019-11-07 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
| CN118978535A (zh) | 2018-05-01 | 2024-11-19 | 锐新医药公司 | 作为mTOR抑制剂的C40-、C28-及C-32连接的雷帕霉素类似物 |
| AU2022253019A1 (en) * | 2021-04-09 | 2023-11-16 | Revolution Medicines, Inc. | Synthesis of rapamycin analog compounds |
| JP2025522296A (ja) | 2022-05-25 | 2025-07-15 | レヴォリューション・メディスンズ，インコーポレイテッド | ｍＴＯＲ阻害剤によりがんを処置する方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04230389A (ja) * | 1990-07-16 | 1992-08-19 | American Home Prod Corp | ラパマイシン誘導体 |
| US5102876A (en) * | 1991-05-07 | 1992-04-07 | American Home Products Corporation | Reduction products of rapamycin |
-
1993
- 1993-08-11 MX MX9304868A patent/MX9304868A/es not_active IP Right Cessation
- 1993-08-12 AT AT93919994T patent/ATE146179T1/de not_active IP Right Cessation
- 1993-08-12 EP EP93919994A patent/EP0655065B1/en not_active Expired - Lifetime
- 1993-08-12 DK DK93919994.9T patent/DK0655065T3/da active
- 1993-08-12 JP JP6506398A patent/JPH08501084A/ja active Pending
- 1993-08-12 CA CA002142288A patent/CA2142288A1/en not_active Abandoned
- 1993-08-12 AU AU50071/93A patent/AU5007193A/en not_active Abandoned
- 1993-08-12 WO PCT/US1993/007581 patent/WO1994004540A1/en not_active Ceased
- 1993-08-12 DE DE69306585T patent/DE69306585T2/de not_active Expired - Fee Related
- 1993-08-12 ES ES93919994T patent/ES2096941T3/es not_active Expired - Lifetime
- 1993-08-12 HU HU9500432A patent/HU221499B/hu not_active IP Right Cessation
-
1997
- 1997-03-03 GR GR970400422T patent/GR3022730T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0655065T3 (enExample) | 1997-02-24 |
| DE69306585D1 (de) | 1997-01-23 |
| ATE146179T1 (de) | 1996-12-15 |
| AU5007193A (en) | 1994-03-15 |
| WO1994004540A1 (en) | 1994-03-03 |
| HUT71614A (en) | 1996-01-29 |
| HU9500432D0 (en) | 1995-04-28 |
| ES2096941T3 (es) | 1997-03-16 |
| EP0655065B1 (en) | 1996-12-11 |
| JPH08501084A (ja) | 1996-02-06 |
| CA2142288A1 (en) | 1994-03-03 |
| DE69306585T2 (de) | 1997-04-17 |
| EP0655065A1 (en) | 1995-05-31 |
| HU221499B (en) | 2002-10-28 |
| MX9304868A (es) | 1994-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0655065T3 (enExample) | ||
| ES2085726T3 (es) | Derivado prolinico de rapamicina, su produccion y aplicacion. | |
| NZ297661A (en) | Hindered N-oxide esters of rapamycin and pharmaceutical compositions | |
| IL96882A0 (en) | Uracil derivatives and pesticides containing the same as active ingredient | |
| TW360678B (en) | Synergistic stabilizer mixture for polyolefins | |
| ATE119774T1 (de) | Imidazopyridinderivate und ihre verwendung. | |
| NL300219I1 (nl) | Tetrahydrofuran antischimmelmiddelen. | |
| NO974890D0 (no) | Radicicolderivater | |
| TW256832B (enExample) | ||
| TW223637B (enExample) | ||
| AU2623192A (en) | Antifungal agent | |
| GB9325618D0 (en) | New herbicides | |
| AP9400632A0 (en) | Ether derivatives. | |
| AU641686B2 (en) | Benzanilides | |
| CA2111955A1 (en) | Novel tetracyclic compound | |
| GR1002598B (el) | Παραγωγα επι-επιβατιδινης. | |
| IE831840L (en) | Cardiotonic agents | |
| AU621996B2 (en) | 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives | |
| UY24327A1 (es) | Derivados de cefalosporina | |
| MY115430A (en) | Glutaramide derivatives. | |
| AU1446892A (en) | Novel oxa- or azasteroid derivative | |
| AU7020996A (en) | UCK14 compounds | |
| AP9400608A0 (en) | "New nicotinic acid derivative". | |
| CA2032311A1 (en) | 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors | |
| DK0565059T3 (da) | Indolderivat |